There’s no specific pattern to torrent pharma. In short term the stock seems weak but there seems to be buying support nearer to 1380-1400 levels.
The main thing with stocks where newsflow is likely to be strong and forthcoming is that any news of an ANDA approval can bump up the stock price in no time.
The current scenario is the time when one must study the story more closely and try to make a case for or against the investment in the company.
disc: invested and adding more recently in the correction.
| Subscribe To Our Free Newsletter |
